Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Change in Accured Expenses (2023 - 2025)

Incannex Healthcare's Change in Accured Expenses history spans 3 years, with the latest figure at $44000.0 for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 101.06% year-over-year to $44000.0; the TTM value through Dec 2025 reached -$3.1 million, down 287.23%, while the annual FY2025 figure was $1.4 million, 54.18% down from the prior year.
  • Change in Accured Expenses for Q4 2025 was $44000.0 at Incannex Healthcare, up from -$5.4 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $3.3 million in Q3 2024 and bottomed at -$5.4 million in Q3 2025.
  • The 3-year median for Change in Accured Expenses is $418500.0 (2025), against an average of -$94400.0.
  • The largest YoY upside for Change in Accured Expenses was 955.04% in 2024 against a maximum downside of 567.79% in 2024.
  • A 3-year view of Change in Accured Expenses shows it stood at $891000.0 in 2023, then plummeted by 567.79% to -$4.2 million in 2024, then soared by 101.06% to $44000.0 in 2025.
  • Per Business Quant, the three most recent readings for IXHL's Change in Accured Expenses are $44000.0 (Q4 2025), -$5.4 million (Q3 2025), and $793000.0 (Q2 2025).